等待开盘 11-06 09:30:00 美东时间
-0.640
-3.52%
electroCore, Inc. announced that its management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 11, 2026, in New York City. Joshua Lev, Co-CEO, President, and CFO, will present at the conference and host investor meetings. Interested investors should contact their Canaccord Genuity sales representative. electroCore specializes in non-invasive bioelectronic technologies, offering produ...
11-05 13:00
electroCore, Inc. will report its Q3 2026 financial results on November 4, 2026, after market close. Management will host a conference call and webcast at 4:30 PM EST that day to discuss the results. Participants can join via telephone (877-407-8835 / +1 201-689-8779) or webcast using the provided link. A replay will be available on the company’s investor website. The company specializes in bioelectronic technologies for health and wellness, with...
10-29 12:00
BHAV Acquisition Corp II announced the pricing of its initial public offering of 10 million units at $10.00 per unit, with each unit including one Class A ordinary share and one right. The units will trade on Nasdaq under "BHAIU," with separate trading expected for shares ("BHAI") and rights ("BHAIR"). Led by CEO Giri Devanur and CFO Chaitanya Kumar Setti, the offering is managed by Maxim Group LLC. The underwriter has a 45-day option to purchase...
10-29 00:30
electroCore, Inc. (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced its participation in the Planet MicroCap Toronto 2026 conference. Joshua Lev, Co-CEO, President, and CFO, will present on October 28 at 9:30 am ET and host investor meetings. The event takes place at Arcadian Court & Loft, 401 Bay St, Toronto, ON, M5H 2Y4. A webcast is available, and investors can register for meetings at planetmicrocap.com. electroCore spe...
10-21 12:00